On September 30, 2015 Fierce Biotech disclosed the 15 selected companies for the Fierce 15 Award. No less than nine of these have solid ties to drug development in oncology (Press release, Fierce Biotech, SEP 30, 2015, View Source [SID:1234507611]). In fact Fierce Biotech has by this choice of companies highlighted the importance of gene editing and cellular therapy in the field of immunotherapy for developing future cures in cancer. Schedule your 30 min Free 1stOncology Demo! List of Oncology Associated Companies Among this Year Recipients of the Fierce 15 Award:
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Arvinas (USA)
Cell Medica (UK)
CRISPR Therapeutics (Switzerland)
Intellia Therapeutics (USA)
NGM Biopharmaceuticals (USA)
SQZ Biotech (USA)
Surface Oncology (USA)
Syros Pharmaceuticals (USA)
Unum Therapeutics (USA)